In a set of pre-treatment samples from 117 cervical cancer patients treated with CRT, the proteins ATM, PARP-1, DNA-PKcs, Ku70 and Ku86 were quantified using fluorescence immunohistochemistry. Here, PARP1 is linked to cervical carcinoma.